Introduction {#s1}
============

The sterility syndrome of 'P-M' hybrid dysgenesis in *Drosophila melanogaster* ([@bib16]; [@bib28]) is due to uncontrolled *P*-element transposition that damages ovarian development and induces female sterility ([@bib6] and reviewed in [@bib26]). This gonadal dysgenesis (GD) phenotype occurs in hybrid F1 daughters whose paternal genome comes from a father possessing active *P*-elements (a '*P*' strain) and a maternal genome unable to express *P*-element piRNAs (an '*M*' strain) ([@bib10]; [@bib27]). The fascinating nature of this genetic syndrome is complete fertility in daughters from the reciprocal cross because the mother possessing active *P*-elements contribute *P*-element-derived Piwi-interacting RNAs (piRNAs) to silence these transposons in daughters ([@bib10]; [@bib27]). Thus, despite identical genetic makeup in daughters between the reciprocal crosses, the epigenetic maternal transmission of transposon repression by piRNAs starkly defines female fertility (illustrated in [Figure 1A](#fig1){ref-type="fig"}).

![No correlation between paternally-induced gonadal dysgenesis (GD) rate and *P*-element copy number.\
(**A**) Illustration of the *P*-element-induced GD phenomenon, where two different types of crosses with one parent lacking *P*-elements while the other parents containing *P*-elements can result in genetically identical daughters having very different gonadal phenotypes. (**B**) GD rates from paternal genome strains mated with *ISO1* females; at least 100 F1 daughters per cross were assayed. (**C**) Genomic quantitative PCR assessment of *P*-element load of strains, normalized to *Har* at 100%. (**D**) Scatterplot comparing TIDAL counts of *P*-element insertions to the GD rate reflects the lack of correlation.\
Figure 1---source data 1.Spreadsheets with the tabulation of gonadal dysgenesis assays and raw values from the qPCR experiments.](elife-49948-fig1){#fig1}

Between fertility and complete sterility lies a spectrum of GD induction variation amongst different strain crosses that may be attributed to differential *P*-element copy numbers in different strain genomes ([@bib2]; [@bib4]; [@bib5]; [@bib6]; [@bib8]; [@bib29]; [@bib46]; [@bib54]; [@bib62]), and capacity to generate piRNAs ([@bib58]). In addition, there are many non-autonomous *P*-element variants that can be mobilized by *P*-transposases, including very short elements from the *pi\[2\]* strain ([@bib6]; [@bib40]) that actually assemble in vitro with the *P*-transposase tetramer complex \>100X more efficiently than the full-length *P*-element ([@bib56]). However, many earlier studies perceived truncated variants such as the '*KP2*' variants as inhibitors of transposition by acting to titrate *P*-transposase since *P-*element piRNAs were unknown at the time ([@bib7]; [@bib19]; [@bib23]; [@bib45]; [@bib51]). Most studies of GD were typically calibrated with a strong paternal inducer *'P'-*strain like *Harwich* (*Har*) or *pi\[2\]* when mated with '*M*' strain females lacking *P*-elements ([@bib6]; [@bib10]; [@bib28]; [@bib47]). Despite over 40 years of study, what defines a strong paternal inducer of GD has remained a mystery.

Although *P*-element copy numbers in *Har* are significant (120--140 copies; [@bib27]), strains with even more copies like *OreR-MOD* do not induce GD whereas other strong inducer strains that have \>75% fewer *P*-element copies than *Har* can also trigger complete GD ([Figure 1B and C](#fig1){ref-type="fig"}). Thus, there is a lack of correlation between *P*-element copy number and GD induction ([Figure 1D](#fig1){ref-type="fig"}) that we and others have previously observed ([@bib4]; [@bib46]; [@bib54]). Since *P*-element copy numbers do not explain GD severity, we hypothesized that a special *P*-element variant or insertion locus might underlie the strong GD phenotype in certain strong '*P*' strains like *Har*. To discover this *P*-element variant, we undertook a reductionist approach to find specific *P*-element variant(s) required for GD induction that revealed unexpectedly a short variant from the *Har* strain that may act together with the full-length *P*-transposase to drive strong GD.

Results {#s2}
=======

GD retention and loss in hybrid *Drosophila* lines with reduced *P*-element copy numbers {#s2-1}
----------------------------------------------------------------------------------------

To genetically isolate the causative transposon strongly inducing GD and facilitate discovery by whole genome sequencing (WGS), we generated hybrid lines where only a minor fraction of the *Har* genome is within the background of the *ISO1* reference genome sequence. We first conducted several fertility-permissive backcrosses between female *Har* and male *ISO1*, selecting hybrid progeny that propagated a red-eye phenotype which we attributed to the 'red' eyes due to *Har* alleles replacing the *cn, bw, sp*, alleles on Chromosome 2R (Chr2R) of *ISO1* ([Figure 2A](#fig2){ref-type="fig"}-abridged scheme, [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}-detailed scheme). We then performed an initial GD validation screen with many vials of individual hybrid males crossed to *ISO1* females and selecting for lines that caused 100% GD from this cross. Lines were propagated with additional self-crosses and further in-bred with single-sibling pairs. We then subjected multiple independent *Har-ISO1-Selfed-Red* (*HISR*) lines to a second GD assay. Finally, we conducted qPCR to identify the lines with the greatest reduction of *P*-element copy numbers ([Figure 2B](#fig2){ref-type="fig"}) and settled on four lines each that either retained severe paternally-induced GD (*HISR-D*) or had lost this capacity (*HISR-N*) ([Figure 2C](#fig2){ref-type="fig"}).

![*HISR* lines retaining or losing strong gonadal dysgenesis (GD) induction.\
(**A**) Abridged scheme for generating hybrid lines retaining a small fraction of the *Har* genome in the *ISO1* background. Full scheme is [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}. (**B**) GD rates from paternal genome lines and strains mated with *ISO1* females. (**C**) Ovarian atrophy phenotype only observed from paternal induction of GD. (**D**) Genome-wide single nucleotide polymorphism profile differences distinct from *ISO1* genome. (**E**) Normalized counts of *P*-element copies by consensus read mapping of genomic libraries. (**F**) qPCR assessment of total genomic *P*-element load.\
Figure 2---source data 1.Spreadsheets with the tabulation of gonadal dysgenesis assays, quantitation of genomewide SNP profiles, calculations of P-element genomic loads, and raw values from the qPCR experiments.](elife-49948-fig2){#fig2}

Genomic PCR genotyping of deletion loci of *Har* compared to *ISO1* in *HISR* lines indicated that these lines carried mostly *ISO1* genomes ([Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}). Therefore, we performed WGS of the parental *Har* and *ISO1* strains, the 8 *HISR* lines, and the *pi\[2\]* and *Birmingham* (*Birm*) strains, two classic strains with similar numbers of *P*-elements but diametric capacity to induce GD ([@bib15]; [@bib49]). Single-nucleotide polymorphism (SNP) profiles of *HISR* lines confirmed that only a small percentage of the *Har* genome was retained in mostly an *ISO1* background ([Figure 2D](#fig2){ref-type="fig"}). Quantification of *P*-element copies from WGS with the TIDAL program (Transposon Insertion and Depletion AnaLyzer, [Figure 2E](#fig2){ref-type="fig"}) ([@bib41]) was also consistent with qPCR measurements ([Figure 2F](#fig2){ref-type="fig"}).

*HISR-D* lines produce similar levels of *P*-element piRNAs as the parental *Har* strain {#s2-2}
----------------------------------------------------------------------------------------

To determine how substantial reduction in *P*-element copy numbers in *HISR* lines affected *P*-element-directed piRNA production, we generated and sequenced highly-consistent ovarian small RNA libraries ([Figure 3A](#fig3){ref-type="fig"}) and confirmed the expected presence and absence of *P*-element piRNAs in *Har* and *ISO1* ovaries, respectively ([Figure 3B](#fig3){ref-type="fig"}). Surprisingly, there were similar-to-increased levels of *P*-element piRNAs between *HISR-D* and *Har* strains, whereas amongst the *HISR-N* lines, only *HISR-N10* retained *P*-element piRNAs ([Figure 3C](#fig3){ref-type="fig"}). Our own mapping analysis indicated a common 3\' end antisense bias of *P*-element piRNAs that we also confirmed with an independent piRNA analysis pipeline ([@bib21]). These mapping patterns are consistent with piRNAs silencing transposons and suppressing hybrid GD ([@bib10]; [@bib17]; [@bib27]) as well as correlating with all the *HISR-D's* and *HISR-N10's* immunity to strong GD induction when these females are mated to *Har* males ([Figure 3D](#fig3){ref-type="fig"}).

![*P*-element directed piRNA production in *HISR* strains ovaries.\
(**A**) Nearly identical size distributions of small RNAs from parental and *HISR* ovaries. (**B**) *P*-element piRNAs coverage plots and (**C**) quantitation of the *P-*element piRNAs mapping to plus and minus strands, in reads per million (RPM). (**D**) Assays for repression of *P*-element induced GD for *HISR* strains (N ≥ 100 females) are a good proxy for production of piRNAs silencing *P-*elements.\
Figure 3---source data 1.Spreadsheets with the calculations for P-element piRNA coverage and tabulation of gonadal dysgenesis assays.](elife-49948-fig3){#fig3}

Additional piRNAs broadly cover the full length of *P*-element in *Har* and *HISR-D* lines ([Figure 3B](#fig3){ref-type="fig"}-top and right), but the notable depletion of internal *P*-element piRNAs in *HISR-N10* ([Figure 3B](#fig3){ref-type="fig"}-middle left) prompted us to conjecture which of its 23 TIDAL-mapped *P*-elements might be stimulating this novel piRNA pattern. We only found one euchromatic *P*-element insertion in *HISR-N10* that specifically coincided with an increase of local piRNAs ([Figure 3---figure supplement 1A](#fig3s1){ref-type="fig"}). This *P*-element inserted into the 5\' UTR of *DIP1*, adjacent to the enhancer and promoter region of *Flamenco*, the major piRNA cluster located in a pericentromeric region of the X-chromosome ([@bib9]). However, when we selected just the *HISR-N10* X-chromosome balanced with the *FM7a* balancer chromosome ([Figure 3---figure supplement 1B](#fig3s1){ref-type="fig"}), this X-chromosome locus did not generate enough *P*-element piRNAs to provide full GD immunity. It is possible for additional *P*-elements to have inserted into major piRNA cluster loci like *42AB*, *Flamenco* and *TAS*-regions as part of the endogenizing process ([@bib27]; [@bib38]), but the intractable repetitiveness of piRNA cluster regions prevents bioinformatic programs from pinpointing *P*-element insertions in these regions. Interestingly, all the *P*-element piRNAs detected in *HISR-N10, -D29*, and parental *Har* appeared to be expressed in the germline due to the detection of clear ping-pong piRNA biogenesis signatures ([Figure 3---figure supplement 2](#fig3s2){ref-type="fig"}). Finally, the *P*-element piRNA patterns in *HISR-N10* can be explained by the abundant *P*-element variant that will be discussed below.

Dispersed *P*-element landscapes indicate de novo transposition in *HISR* lines {#s2-3}
-------------------------------------------------------------------------------

The selection for 'red' eyes of *Har* alleles in *HISR* lines should have replaced the *cn, bw, sp*, alleles on Chromosome 2R (Chr2R) of *ISO1*, therefore we had hoped that WGS of *HISR* line genomes might to point to a specific set of *P-*elements responsible for inducing strong GD. Unexpectedly, the *P*-element insertions were not confined to Chr2R, but rather were dispersed across the entire genomes of all *HISR* lines ([Figure 4A](#fig4){ref-type="fig"}), seemingly defying the genomic PCR genotyping and WGS-SNP profiling that indicated sufficient backcrossing to favor mostly the *ISO1* genetic background ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}).

![*P-elements* are mobilized de novo during generation of *HISR* lines.\
(**A**) TIDAL program counts of novel *P-*element insertions, left Y-axis and colored bars. Right Y-axis, black dots and dashed line are the total distinct transposon insertions in the unique-mapping portion of genome. (**B**) Lineage analysis of the *Har P*-elements retained in the *HISR* lines, colored by the major chromosomal segments. (**C**) Comparison of shared *P*-elements between *Har* and *HISR* lines, with total number of *P*-elements called by TIDAL in the top row and first column. Color shade reflects degree of shared *P*-elements between the two strains being compared.\
Figure 4---source data 1.Spreadsheets with the calculations of P-element locus comparisons amongst the HISR strains and the records of the de novo P-element insertions amongst the HISR strains.](elife-49948-fig4){#fig4}

To explore this conundrum, we examined how many of the original *P*-elements in the *Har* genome were conserved in the *HISR* lines' genomes ([Figure 4B](#fig4){ref-type="fig"}). As expected for *HISR-D29* whose *P*-element copy numbers was closest to *Har*, this line conserved the highest share of parental *Har P*-elements compared to other *HISR* lines. However, there were also 35 novel *P*-element insertions (\~45%) in *HISR-D29* absent from *Har*. Surprisingly, the vast majority of the *P*-element insertions across all *HISR* lines were also de novo P-element insertions ([Figure 4C](#fig4){ref-type="fig"}), with each line clearing out nearly all parental *Har P*-element insertions and developing unique landscapes of *P-*element insertions. These data suggest that during the course of stabilizing the *HISR* lines, there were bursts of new *P*-element transpositions resulting in novel transposon landscapes that are completely distinct from the parental *Har* genome.

Although this dispersion of de novo P-elements in *HISR* lines' genomes stymied our goal to pinpoint a particular *Har* locus strongly inducing GD, we next cloned and sequenced genomic PCR amplicons of all *P*-elements from the various *P*-element-containing strains. By using a single oligonucleotide that primes from both the 5\' and 3\' Terminal Inverted Repeats (TIRs), we amplified full-length *P*-elements as well as several additional truncation variants ([Figure 5A](#fig5){ref-type="fig"}) that have been missed in other genomic PCR assays using internal primers ([@bib58]). The most abundant variant accounting for more *P*-element copies in *OreR-MOD* and *OreR-TK* strains compared to *Har* were the '*KP*' variant shown to encode a dominant negative protein that inhibits full-length *P*-transposase activity ([@bib23]; [@bib50]) ([Figure 5A--5C](#fig5){ref-type="fig"}), thus explaining the innocuous accumulation of these *P*-element variants in these *OreR* strains. Full-length *P*-elements were also sequenced from *Har*, *pi\[2\]* and *Lerik-P* strains, but there were no sequence differences in these clones from the original full-length *P*-element sequence in GenBank that might suggest a superlative quality to the full-length *P*-element in these strong GD-inducing strains.

![*Har-P* is a short and highly mobile *P-*element variant in strains used in *P*-element GD assays.\
(**A**) *P*-element variant amplicons generated with TIR primers were cloned and sequenced as marked by colored arrows for the sequenced diagrams in (**B**). (**B**) Diagram of *P*-element variants cloned and sequenced from genomic PCR amplicons shown above. (**C**) Genomic qPCR quantifications of three *P*-element variants in *Harwich* and *Harwich*-derived *HISR* lines. Relative quantifications (in percentage) were calculated from ΔΔCt with *rp49* as reference gene. (**D**) Proportions of the *P-*element variants verified by locus-specific PCR from TIDAL predictions of all *HISR-N* and *HISR-D* strains with \<40 *P-*element insertions. The gel for *HISR-N17* is on the right, while remaining gels are in [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}.\
Figure 5---source data 1.Spreadsheets with the raw values from the qPCR experiments and calculations of the percentage of the insertions corresponding to the three P-element variant types.](elife-49948-fig5){#fig5}

Interestingly, we sequenced short \~630 bp *P*-element variants that were all very similar in configuration in *Har*, *pi\[2\]*, and *Birm* strains, which only retains \~130 bp of the 5\' end and \~500 bp of the 3\' end of the *P*-element ([Figure 5A and B](#fig5){ref-type="fig"}). By retaining functional TIRs, these short elements can still be detected by TIDAL in WGS, can mobilize during crosses with the *pi\[2\]* strain ([@bib6]; [@bib39]; [@bib40]); and were previously shown to be able to assemble in vitro with the *P*-transposase tetramer complex \>100X more efficiently than the full-length *P*-element ([@bib56]). In addition, these short *P*-element variants seemed unlikely to translate into a protein due to multiple premature stop codons introduced by the massive internal deletion.

In all *HISR-D* lines that retain strong GD induction, we detected this short *P*-element variant and the full-length *P*-element encoding *P*-transposase, whereas the *HISR-N* lines retained the short variant but appeared to have lost the full-length *P*-element ([Figure 5A](#fig5){ref-type="fig"}, right panel). With the smaller number of TIDAL-predicted *P-*element insertions in *HISR-N* lines, we confirmed by locus-specific PCR the absence of full-length *P*-elements and that the majority of *P*-element insertions (\~55--95%) were these de novo short *P*-element insertions ([Figure 5D](#fig5){ref-type="fig"} and [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}). We name this short variant '*Har-Ps*' (*Harwich P's*) in homage to Harpies, highly mobile hybrid bird-human creatures from the Greek mythological stories of the Argonauts.

To further support the conclusion that *Har-P*-like elements are the ammunition to drive severe GD, we examined additional fly lines from the DGRP collection ([@bib35]) which are of completely independent origin from *Har*, *pi\[2\]*, and *Birm* strains. Indeed, the strains *RAL-42* and *RAL-377* that cause severe GD despite having a fraction of the load of *P-elements* as *Har* also possessed *Har-P-like* short variants ([Figure 5---figure supplement 2](#fig5s2){ref-type="fig"}). Meanwhile, two other *P-element*-containing strains *RAL-508* and *RAL-855* did not induce GD because only the longer *KP*-like elements were present ([Figure 5---figure supplement 2](#fig5s2){ref-type="fig"}).

Restoring GD when *Har-P* is crossed with *P*-transposase expressed in the germline {#s2-4}
-----------------------------------------------------------------------------------

We hypothesized that *Har-Ps* combined with *P*-transposase from full-length *P*-elements could be the drivers of strong GD induction from *pi\[2\]*, *Har*, and *HISR-D* strains. To test this hypothesis, we used negative-control *yw*-background females that lack *P*-transposase and transgenic *H{CP}*3 females that only express *P*-transposase in the germline ([@bib52]) in crosses with males that either lack *Har-P* copies (*ISO1, Lerik-P, OreR-MOD*) or contain many *Har-P* copies (*Har, HISR-N's, Birm*)([Figure 6A](#fig6){ref-type="fig"}). GD induction was only restored in the F1 daughters of this cross in strains with many *Har-Ps* ([Figure 6B](#fig6){ref-type="fig"}). To avoid silencing of *P*-transposase by maternal *P*-element piRNAs in these strains, these crosses specifically used males that should only contribute paternal chromatin without contributing piRNAs ([Figure 6A](#fig6){ref-type="fig"}). Notably, the *KP*-length and full-length *P*-elements in *OreR-MOD* and *Lerik-P*, respectively, did not restore GD ([Figure 6B](#fig6){ref-type="fig"}, right most bars of left graph). These results suggest *P*-transposase act upon *Har-P* loci rather than longer *P*-element variants to induce GD and support the observation for *Har-P* loci making up the majority of the de novo *P*-element insertions in *HISR-N* lines ([Figure 6C](#fig6){ref-type="fig"}). Our data now genetically explain a previously described biochemical result showing that *P*-transposase assembles much more efficiently in vitro on short *P*-elements compared to the full-length *P*-element ([@bib56]).

![In absence of piRNA silencing, *Har-P* crossed with *P*-transposase restores severe GD.\
(**A**) Strains for testing *Har-P* genetic interaction with *P*-transposase activity. \*-strains with piRNA silencing; †-strains lacking any *P*-elements. (**B**) The *H{CP}*3 strain's moderately-expressed maternal dose of *P*-transposase crossed with paternal *HISR-N* strains and *Birm* strain restores GD in F1 daughters, but strains with longer and full-length *P*-elements like *OreR-MOD* and *Lerik-P* lack the GD phenotype. (**C**) Model for *P*-transposase mobilizing *Har-Ps* to cause catastrophic transposition.\
Figure 6---source data 1.Spreadsheet with the tabulation of gonadal dysgenesis assays.](elife-49948-fig6){#fig6}

We noticed that GD severity in crossing *HISR-N* with the *H{CP}3* transgenic line was not completely penetrant like GD assays with the parental *Har* ([Figure 6B](#fig6){ref-type="fig"} versus [Figure 1B](#fig1){ref-type="fig"}) because *Har* contributes both multiple copies of full-length *P*-elements and *Har-P* loci versus the single copy of the natural *P*-element transgene in *H{CP}3* ([@bib52]). In addition, natural *P*-element translation is inhibited by strong somatic splicing inhibition of the native *P*-element's third intron (IVS3) containing a premature stop codon and only inefficient splicing in the *Drosophila* germline that is further suppressed by piRNAs ([@bib48]; [@bib57]). We also confirmed that IVS3 intron splicing was the main alteration that increased *P*-element expression in ovaries from a dysgenic cross between *Har* and *ISO1*, whereas Open Reading Frame (ORF) parts of the *P*-element transcript are only modestly increased ([Figure 6---figure supplement 1A](#fig6s1){ref-type="fig"}). We believe this sufficient expression of *P*-transposase promotes the preferred mobilization of *Har-P* short variants in dysgenic cross ovaries, but the cut-and-paste transposition mechanism of *P*-transposase should theoretically conserve the total copy number of *P*-elements. By using digital droplet PCR to precisely quantity total *P*-element copy numbers, we confirmed that total *P*-element copy numbers were stable across ovaries of daughters from two sets of dysgenic and non-dysgenic crosses ([Figure 6---figure supplement 1B](#fig6s1){ref-type="fig"}).

Somatic expression of *P*-transposase with *Har-P's* causes pupal lethality {#s2-5}
---------------------------------------------------------------------------

To test whether a stronger expressing *P*-transposase transgene could induce the complete GD in crosses with *HISR-N* lines, we turned to the *delta\[2-3\] P*-transposase transgenes that lack the IVS3 intron to enable strong somatic and germline *P*-transposase activity ([@bib44]). When we crossed two different *delta\[2-3\]* female strains to males of *HISR-N17*, *-N25*, and *-N31* which lack *P*-element piRNA expression but have *Har-Ps,* we were unable to assay GD because of extensive pupal lethality ([Figure 7A](#fig7){ref-type="fig"}). We also confirmed extensive pupal lethality in crosses between *delta\[2-3\]* and the *Birm* strain ([Figure 7A](#fig7){ref-type="fig"}) as previously described ([@bib15]; [@bib49]). Since we also detected very short *P* variants in *Birm* that are similar to *Har-P* ([Figure 5A and B](#fig5){ref-type="fig"}) we conclude that somatically expressed *P*-transposase acting only on the *Har-Ps* in *Birm*, *HISR-N17*, *-N25*, and *-N31* is sufficient to disrupt pupal development.

![Somatic expression of *P*-transposase triggers pupal lethality with *Har-P* loci that are not silenced by *P-element* piRNAs.\
(**A**) Green triangles denote crosses showing pupal lethality from stronger somatic expression of *P*-transposase acting on *Har-Ps* in *HISR-N* and *Birm* strains lacking *P*-element piRNAs. Red hexagons denote crosses with strains expressing *P*-element piRNAs that suppress pupal lethality through a paternally transmitted epigenetic imprint. (**B**) The paternal *P*-element piRNA imprinting on *Har-Ps* in *Har* and *HISR-N10* cannot suppress GD in F1 daughters, as marked by green triangles. The longer *P* variants in *OreR-MOD* do not result in GD with the *delta\[2-3\] P-*transposase. (**C**) Revised *P* Dysgenesis paradigm proposing a paternally-transmitted piRNA-directed epigenetic mark that resists *P*-transposase activity in the soma, but this mark is erased during oogenesis.\
Figure 7---source data 1.Spreadsheets with the tabulation of pupal lethality and gonadal dysgenesis assays.](elife-49948-fig7){#fig7}

Unexpectedly, the pupal lethality was suppressed when *delta\[2-3\]* females were crossed with *Har-P*-containing males that also expressed *P*-element piRNAs, such as *Har*, *pi\[2\]*, the four *HISR-D* lines, and *HISR-N10* ([Figure 7A](#fig7){ref-type="fig"}). These hybrid F1 progeny developed into adults, but the adult females of *Har* and *HISR-N10* hybrids with *delta\[2-3\]* still exhibited severe GD ([Figure 7B](#fig7){ref-type="fig"}). In addition, we also observed severe pupal lethality when *delta\[2-3\]* females were crossed to *RAL-42* but not *RAL-377*, although strong GD was still observed with *RAL-377* ([Figure 7---figure supplement 1](#fig7s1){ref-type="fig"}). These *RAL* strains of independent origin from *Har*, *pi\[2\]*, and *HISR* lines provide convincing support for the conclusion that *P*-element piRNAs impart a paternally-transmitted imprint on *Har-P* loci that resists mobilization with somatically-expressed *P*-transposase and enables development to adulthood. However, this imprint is either erased in ovaries or insufficient to prevent ovarian GD. Finally, the notable *P*-element piRNA pattern of *HISR-N10* perfectly matches the *Har-P* structure since many internal piRNAs are absent ([Figure 3B](#fig3){ref-type="fig"}), but overall *P*-element piRNAs in *HISR-N10* are equivalent to *Har* and *HISR-D* lines ([Figure 3C](#fig3){ref-type="fig"}), and therefore are sufficient to repress *Har-P's* epigenetically from being mobilized in the soma by the *delta\[2-3\] P*-transposase.

Discussion {#s3}
==========

After a *Drosophila* strain has silenced an invading transposon through the Piwi/piRNA pathway, the neutered transposon will naturally decay into various truncations that are presumed to be neutral or even beneficial to host fitness ([@bib26]), such as natural *KP2* truncation variants that inhibit *P*-element transposition ([@bib23]; [@bib50]). However, we discovered one such truncation we call *Har-P* via our unbiased genetic and molecular approach that can actually be detrimental to the host. Our findings resonate with the previous finding that *P*-transposase assembles in vitro much more efficiently on very short natural *P*-element variants ([@bib56]), therefore we propose a new model for catastrophic *P*-element transposition in strong GD inducer strains like *pi\[2\]* and *Har* ([Figure 6C](#fig6){ref-type="fig"}).

When a *P*-element truncates to a \~630 bp *Har-P* variant, this non-autonomous variant dominates as the main mobilizing *P*-element during a dysgenic cross to induce strong GD. Thus, previous studies examining GD variability across other *Drosophila* strains and isolates may now be explained by whether these genomes contain both full length and very short *P*-elements ([@bib4]; [@bib30]; [@bib46]; [@bib54]; [@bib58]; [@bib62]). Moreover, this particular deletion size of a \~630 bp *P*-element variant that arose in at least four completely independent lines has persisted without detriment to these animals either because of piRNA silencing (i.e. *Har*, *pi\[2\]*, *RAL-377*) or because the *P*-transposase was separated (i.e. *HISR-N* and *Birm*). The short configuration must be special because additional sequence lengths such as *P*-element-based transgenes that were mobilized by *P*-transposase into transgenic strains are not strong triggers of GD like the *Har-P* elements ([Figure 7---figure supplement 1C](#fig7s1){ref-type="fig"}).

Although our future goal will be to determine which specific epigenetic marks are deposited at full length *P*-elements and *Har-P's* by piRNAs, we believe a chromatin mark resisting *P*-transposase activity is more likely than somatic piRNAs or siRNAs ([@bib11]; [@bib18]; [@bib25]) silencing the *delta\[2-3\] P*-transposase in our pupal lethality crosses because we confirmed robust *P-*transposase mRNA expression regardless of the expression of *P*-element piRNAs ([Figure 7---figure supplement 2A](#fig7s2){ref-type="fig"}). A second future goal will be to generate transgenic flies with single or multiple synthetic *Har-P* copies to determine the precise dosage of *Har-P's* that would trigger GD or pupal lethality. However, in addition to copy number, genomic location may also influence host tolerance of *Har-P's*, because we observed a significant rescue of viable pupae in crosses between *delta\[2-3\] P*-transposase and a derivative strain of *HISR-N17* with *Har-P's* only on Chromosome 3 with six *P*-elements, while no pupae survived with *delta\[2-3\] P-*transposase and *Har-P's* on Chromosome 2 with nine *P*-elements ([Figure 7---figure supplement 2B](#fig7s2){ref-type="fig"}).

The *Drosophila P*-element system of hybrid GD mainly affects female sterility and requires maternally contributed *P*-element piRNAs to propagate transgenerational *P*-element silencing in daughters via trimethylation of histone H3 lysine 9 (H3K9me3) ([@bib24]; [@bib33]). Although previous studies of dysgenic crosses focused on complete GD in females ([@bib6]; [@bib10]; [@bib27]; [@bib47]), sons respond differently because they are fertile despite presumed somatic *P*-element excision ([@bib59]). Since previous studies of *P-M* hybrid dysgenesis above never considered a paternal imprint on *P*-elements that our findings now suggest is being propagated ([Figure 7C](#fig7){ref-type="fig"}), future studies with *HISR-N* strains will enable us to dissect a paternally-transmitted small RNA-directed silencing effect in *Drosophila* that harkens to also a similar paternally-transmitted RNAi effects observed earlier in nematodes ([@bib20]).

Mouse piRNAs bound by MIWI2 direct the re-establishment of DNA methylation marks on transposons like *L1* and *IAP* ([@bib3]), which may propagate in sperm, but *Drosophila* DNA methylation is not prominent ([@bib31]). Similar to other metazoans, *Drosophila* sperm also undergoes histone exchange with protamines (ProtB), with little contribution of paternal cytoplasm ([@bib43]). However, recent data do support the retention of some H3K9me3 in sperm ([@bib60]), which might underlie the paternal imprint of piRNA-silencing of *P*-elements that will be investigated further in future studies.

This interplay between the truncated *Har-Ps* and full-length *P*-element DNA transposon resembles other examples in nature, such as the extreme proliferation of MITEs (miniature inverted repeat transposable element) in rice scavenging other transposases to mobilize ([@bib61]), and short mammalian SINEs retrotransposons taking advantage of the transposition machinery of longer LINEs, since SINEs persist in much greater numbers than their longer LINE counterparts ([@bib22]). However, while the full impact of MITEs and SINEs on organism development is still obscure, our study indicates that *Har-Ps* combined with the *P*-transposase to trigger transposition events so efficiently to be detrimental to ovarian and pupal development. Notwithstanding, the high efficiency of *Har-P* mobilization *by P*-transposase may also be engineered into a new generation of transposon-based mutagenesis approaches.

Materials and methods {#s4}
=====================

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type (species) or resource                      Designation                                                   Source reference                   Identifier                                                       Additional information
  ------------------------------------------------------- ------------------------------------------------------------- ---------------------------------- ---------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------
  Strain, strain background (*Drosophila melanogaster)*   *ISO1*                                                        Susan Celnicker Lab                PMID: [25589440](https://www.ncbi.nlm.nih.gov/pubmed/25589440)   iso-1 : y\[1\]; Gr22b\[1\] Gr22d\[1\] cn\[1\] CG33964\[R4.2\] bw\[1\] sp\[1\]; LysC\[1\] MstProx\[1\] GstD5\[1\] Rh6\[1\]

  Strain, strain background (*Drosophila melanogaster)*   *Harwich*                                                     William Theurkauf Lab              PMID: [22196730](https://www.ncbi.nlm.nih.gov/pubmed/22196730)   

  Strain, strain background (*Drosophila melanogaster)*   *HISR-D29*                                                    Created in Lau Lab                 This paper                                                       

  Strain, strain background (*Drosophila melanogaster)*   *HISR-D43*                                                    Created in Lau Lab                 This paper                                                       

  Strain, strain background (*Drosophila melanogaster)*   *HISR-D46*                                                    Created in Lau Lab                 This paper                                                       

  Strain, strain background (*Drosophila melanogaster)*   *HISR-D51*                                                    Created in Lau Lab                 This paper                                                       

  Strain, strain background (*Drosophila melanogaster)*   *HISR-N10*                                                    Created in Lau Lab                 This paper                                                       

  Strain, strain background (*Drosophila melanogaster)*   *HISR-N17*                                                    Created in Lau Lab                 This paper                                                       

  Strain, strain background (*Drosophila melanogaster)*   *HISR-N25*                                                    Created in Lau Lab                 This paper                                                       

  Strain, strain background (*Drosophila melanogaster)*   *HISR-N31*                                                    Created in Lau Lab                 This paper                                                       

  Strain, strain background\                              *H{KP}*                                                       BDSC                               Stock No. 64175                                                  y\[1\] w\[67c23\]; H{w\[+mC\]=KP}H 
  (*Drosophila melanogaster)*                                                                                                                                                                                               

  Strain, strain background (*Drosophila melanogaster)*   *pi\[2\]*                                                     BDSC                               Stock No.2384                                                    

  Strain, strain background (*Drosophila melanogaster)*   *OreR-MOD*                                                    BDSC                               Stock No.25211                                                   

  Strain, strain background (*Drosophila melanogaster)*   *OreR-TK*                                                     BDSC                               Stock No.2376                                                    

  Strain, strain background (*Drosophila melanogaster)*   *OreR-TOW*                                                    Terry Orr-Weaver\'s Lab            PMID: [21177974](https://www.ncbi.nlm.nih.gov/pubmed/21177974)   

  Strain, strain background (*Drosophila melanogaster)*   *RAL-42*                                                      BDSC                               Stock No.28127                                                   

  Strain, strain background (*Drosophila melanogaster)*   *RAL-377*                                                     BDSC                               Stock No.28186                                                   

  Strain, strain background (*Drosophila melanogaster)*   *RAL-508*                                                     BDSC                               Stock No.28205                                                   

  Strain, strain background (*Drosophila melanogaster)*   RAL-855                                                       BDSC                               Stock No.28251                                                   

  Strain, strain background (*Drosophila melanogaster)*   *H{CP}3*                                                      BDSC                               Stock No.64160                                                   y\[1\] w\[67c23\]; H{w\[+mC\]=hsp/CP}3 PMID: [12019234](https://www.ncbi.nlm.nih.gov/pubmed/12019234)

  Strain, strain background (*Drosophila melanogaster)*   *yw*                                                          John Abrams\'s Lab                 PMID: [26701264](https://www.ncbi.nlm.nih.gov/pubmed/26701264)   

  Strain, strain background (*Drosophila melanogaster)*   *P{delta\[2-3\]}99B*                                          BDSC                               Stock No.3629                                                    w\[\*\]; wg\[Sp-1\]/CyO; ry\[506\] Sb\[1\] P{ry\[+t7.2\]=Delta2-3}99B/TM6B, Tb\[+\] PMID: [3000622](https://www.ncbi.nlm.nih.gov/pubmed/3000622)

  Strain, strain background (*Drosophila melanogaster)*   *H{P delta\[2-3\]}*                                           BDSC                               Stock No.64161                                                   y\[1\] w\[67c23\]; H{w\[+mC\]=w\[+\].Delta2- 3.M}6

  Strain, strain background (*Drosophila melanogaster)*   *P{TubGal80}Chr2*                                             BDSC                               Stock No.7108                                                    

  Strain, strain background (*Drosophila melanogaster)*   *P{TubGal80}Chr3*                                             BDSC                               Stock No.7017                                                    

  Strain, strain background (*Drosophila melanogaster)*   *P{Elav-Gal4}Chr2*                                            BDSC                               Stock No.8765                                                    

  Strain, strain background (*Drosophila melanogaster)*   *Sp/CyO;TM6b/Sb*                                              Michael Rosbash\'s Lab                                                                              

  Strain, strain background (*Drosophila melanogaster)*   *Lerik-P*                                                     Stephane Ronsseray\'s Lab          PMID: [1660427](https://www.ncbi.nlm.nih.gov/pubmed/1660427)     Lk-P(1A)-SL2

  Strain, strain background (*Drosophila melanogaster)*   *Birm*                                                        BDSC                               Stock No. 2359                                                   Birm Chr2; PMID: [2835286](https://www.ncbi.nlm.nih.gov/pubmed/2835286)

  software, algorithm                                     QuantaSoft Analysis Pro                                       Bio-Rad                                                                                             

  software, algorithm                                     Applied Biosystems 7500/7500 Fast Real-Time PCR System v2.0   Applied Biosystems                                                                                  

  software, algorithm                                     BWA MEM                                                       [@bib34]                           PMID: [20080505](https://www.ncbi.nlm.nih.gov/pubmed/20080505)   

  software, algorithm                                     TIDAL-Fly                                                     [@bib41]                           PMID: [26578579](https://www.ncbi.nlm.nih.gov/pubmed/26578579)   

  software, algorithm                                     GATK                                                          [@bib37]                           PMID: [20644199](https://www.ncbi.nlm.nih.gov/pubmed/20644199)   

  commerical assay or kit                                 TOPO PCR Cloning Kit                                          ThermoFischerSci                   Cat No. 450031                                                   

  commerical assay or kit                                 Luna Universal qPCR master mix                                New England Biolabs Inc            Cat No. M3003                                                    

  commerical assay or kit                                 NEB Ultra II FS DNA library prep                              New England Biolabs Inc            Cat No. E7805                                                    

  commerical assay or kit                                 First Strand cDNA Synthesis Kit using ProtoScript II          New England Biolabs Inc            Cat No. M0368                                                    

  commerical assay or kit                                 NEBNext Small RNA Library Prep Set for Illumina               New England Biolabs Inc            Cat No. E7330                                                    

  commerical assay or kit                                 QX200 ddPCR EvaGreen Supermix                                 Bio-Rad                            Cat No. 1864034                                                  

  Chemical compound, drug                                 Tri-reagent                                                   Molecular Research Center Inc,OH                                                                    

  Chemical compound, drug                                 Q Sepharose Fast Flow, 300 mL                                 GE HealthCare                      Cat No. 17051001                                                 
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Fly strains {#s4-1}
-----------

All strains were maintained on standard cornmeal medium at 22°C. Because the *ISO1*(BDSC\#2057) stock had accumulated \>180 new transposon insertions relative to the original stock sequenced in the Berkeley *Drosophila* genome project ([@bib1]; [@bib41]), we obtained the *ISO1* strain from Susan Celniker's lab (*ISO1-SC*). The *Har* strain was obtained from (*Har-WET*) was obtained from the William Theurkauf's lab ([@bib27]). Three *Oregon-R* strains were obtained from Terry Orr-Weaver's lab, *OreR-TOW*, *OreR*-TK (Kaufman, BDSC\#2376) and *OreR-MOD* (BDSC\#25211). The *Lerik-P* strain was obtained from Stephane Ronserray's lab ([@bib24]; [@bib36]). All the following strains were also directly obtained from the BDSC -- *RAL-42* (\#28127), *RAL-377* (\#28186), *RAL-508* (\#28205), *RAL-855* (\#28251), *pi\[2\]* (\#2384), *y\[1\] w\[67c23\]; H{w\[+mC\]=hsp/CP}3* (\#64160), *Birmingham; Sb\[1\]/TM6* (\#2539), *w\[\*\]; wg\[Sp-1\]/CyO; ry\[506\] Sb\[1\] P{ry\[+t7.2\]=Delta2-3}99B/TM6B, Tb\[+\]* (\#3629), *y\[1\] w\[67c23\]; H{w\[+mC\]=w\[+\].Delta2-3.M}6* (\#64161), H{w\[+mC\]=KP} (\#64175), P{TubGal80}Chr2 (\#7108), P{TubGal80}Chr3 (\#7017), and P{Elav-Gal4}Chr2 (\#8765). *Sp/CyO;TM6b/Sb* was obtained from Michael Rosbash's lab.

Crosses, gonadal dysgenesis and pupal lethality assays {#s4-2}
------------------------------------------------------

All crosses were set up with 3--5 virgin females and 2--4 young males per replicate on standard cornmeal medium at 25°C and parents were purged after 5 days of egg laying ([@bib54]). For GD assays, F1 females aged to 4--5 days at 25°C were examined for GD using food dye and GD % shown is average of 3 replicate crosses with total minimum of 100 F1 females assayed ([@bib53]). Somatic pupal lethality was recorded by counting dead (uneclosed) and empty pupae (eclosed) 6 days after first eclosion was observed in respective control cross (*P{delta\[2-3\]}99B x ISO1* or *H{P delta\[2-3\]} x ISO1*) ([@bib15]). Pupal lethality percentage shown is average of two or more replicate crosses that obtained at least total of 50 F1 pupae each.

Crossing scheme to generate *HISR* lines {#s4-3}
----------------------------------------

The detailed crossing scheme is illustrated in [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}. After a first cross between virgin *Har* females and *ISO1* males, three more backcrosses of virgin *Har/ISO1* hybrid progeny females mated to *ISO1* males were performed and following the progeny with red eyes to select for the *Har* segment segregating with the *cn*, *bw, sp*, alleles on Chromosome 2R. We hoped that a particular set of *P*-elements that drive strong GD induction would co-segregate with red eye color. We then performed a 'Validation Cross' with the F4 hybrid males individually mated to *ISO1* females. We screened \>100 individual groups of F4 males for their GD induction, where the early-hatching 3 day old daughters were screened via the squash assay for 100% GD. Only the F5 vials showing 100% GD from F4 males crossed to *ISO1* females were kept, and then were allowed to age and self-crossed and propagated in 11 more generations to attempt to create recombining-inbred-lines (RILs).

Selecting only flies with red eyes required purging any flies emerging with the 'white' eyes of *ISO1* and discarding many vials that failed to generate progeny due to genotoxic collapse from inability to silence *P*-element transposition. At the F16 stage, [H]{.ul}ar/[I]{.ul}SO1 [S]{.ul}elfed [R]{.ul}ed (*HISR)* lines males were rescreened in a Validation Cross with *ISO1* females, this time keeping lines that still caused 100% GD and designated as *HISR-D* (Dysgenic) lines. We also selected additional lines that had now lost GD and allowing for \>50% of females to generate egg chambers, and these were designated *HISR-N* (Non-dysgenic) lines. We performed 2 rounds of single-sibling pair mating to further inbreed these lines in an attempt to stabilize the genotypes, and we maintained 4 lines of each *HISR-D* and *HISR-N* for true propagation of just the red or cinnabar eyes and speck phenotype.

Genomic DNA extraction, PCR, quantitative-PCR and Droplet Digital PCR {#s4-4}
---------------------------------------------------------------------

Genomic DNA was prepared from 10 young female flies by homogenizing tissues with plastic pestle in 300 µL Lysis buffer (10 mM Tris pH-8.0, 100 mM NaCl, 10 mM EDTA, 0.5% SDS, and Proteinase K at 50 µg/ml) and incubated at 65°C overnight followed by treatment of RNase A at 100 µg/ml at 37°C for 30 mins. 200 µL of 0.5M NaCl was added followed by one volume of Phenol:CHCl~3~:IAA (at 25:24:1) and spun at 14,000 rpm for 10 min to isolate DNA in aqueous phase. Aqueous phase was extracted again with one volume of CHCl~3~:IAA (at 24:1) and supplemented with one volume of 5M LiCl and incubated at −20°C and then spun at 15,000 rpm for 15 mins to precipitate RNA. Supernatant was isolated and supplemented with 2 volumes of 100% ethanol and incubated in −20°C for 2 hr and then spun at 15,000 rpm for 20 mins. DNA pellet was washed with chilled 70% ethanol and dissolved in nuclease free water. DNA integrity checked (\>10 kb) by running 1 µg on 1% agarose gel with EtBr.

Genomic PCR reactions to characterize *P*-element structural variation were set up in 30 µL reactions of 1X NEB GC buffer, 300 µM dNTPs, 0.5M Betaine, 2.5 mM MgCl~2~, 0.25 µM of IR primer ([@bib42]), 1 µL of Phusion polymerase and 50 ng of genomic DNA and cycled at 94°C for 1 min, 62°C for two mins, 72°C for 4 mins for 27 cycles and followed by 72°C for 15 min. Genomic PCR reactions to characterize *P*-element structural variation in *HISR* lines, predicted by TIDAL were also set up similarly using *P*-element insertion locus specific primers. Genomic PCR reactions for genotyping of *HISR-N* lines were set up similarly but cycled at 94°C for 30 s, 60°C for 15 s, 72°C for 30 s for 27 cycles and followed by 72°C for 5 min.

Genomic qPCR experiments were performed in three biological replicates with two 20 µL technical reactions replicates each, using Luna Mastermix (NEB), primers at 0.5 µM and 20 ng of genomic DNA per reaction in real time quantitative PCR. *P*-element load was calculated from 2\^(-∆∆Ct) normalized to *Har* at 100% and ∆Ct from *RP49*. All primers used for are listed in [Supplementary file 1](#supp1){ref-type="supplementary-material"}.

For the Droplet Digital PCR (ddPCR), we utilized the Evagreen Mastermix (Biorad) and conducted on a QX500 ddPCR machine with manual setting of droplet signal thresholds. 10--15 pairs of ovaries and corresponding carcass from 4 to 5 day old F1 females were dissected from dysgenic and non-dysgenic crosses of *Har* and *HISR-D51* with *ISO1* strain at 18 °C. DNA was extracted from the ovaries and carcass and quantified using Qubit 2.0 Fluorometer. Digital PCR probe assays were conducted in 40 µL droplet reactions, generated from 25 µL digital PCR reaction and 70 µL droplet oil each. 25 µL digital PCR reactions were set up with BioRad ddPCR probe supermix, *P*-element7a (FAM) and rp49 (HEX) probes each at 250 nM and 200 pg of DNA. Reactions were cycled at 95 °C for 10 mins followed by 95 °C for 30 s and 58 °C for 1 min for 40 cycles, and 98 °C for 10 mins. Copies/µL values were extracted from QuantaSoft (BioRad) software and *P*-element copies per genome were calculated normalized to rp49.

*P*-element amplicon cloning and sequencing {#s4-5}
-------------------------------------------

*P*-elements amplified from IR PCR were purified from 1% agarose gel using QIAquick Gel extraction kit and cloned into pCR4-TOPO vector using Zero Blunt TOPO PCR Cloning Kit at RT, followed by transformation of chemically competent DH10β cells, which were then grown on LB plates with 0.05 mg/ml Kanamycin overnight. 5--10 colonies were screened by PCR and two colonies positive for *P*-element cloned were chosen for plasmid mini-prep and sequenced using M13 forward and reverse primers for all variants in addition to internal primers to complete the sequencing of full-length *P*-elements.

Whole genome sequencing, SNP profile analysis, and TIDAL analysis {#s4-6}
-----------------------------------------------------------------

Genomic DNA libraries were prepared using NEB Ultra II FS kit E7805. Briefly, 500 ng of genomic DNA (\>10 kb) was fragmented at 37°C for 12 min, followed by adaptor ligation and loop excision according to kit manual protocol. Size selection was performed with two rounds of AmpureXP beads addition to select for insert size 150--250 bp as per kit manual. Library PCR amplification was also carried out as per manual instructions for six cycles and purified using one round of AmpureXP beads addition at 0.9X volume. Individual barcoded libraries were quantified on NanoDrop and each diluted to 2 nM and then pooled to produce equimolar concentration.

Whole genome sequencing was performed on an Illumina NextSeq 500 with paired-end reads of 75 bp x 75 bp in the Rosbash lab at Brandeis University. Reads were demultiplexed and trimmed by Trimmomatic to remove low quality bases, and then reads were analyzed by the TIDAL program ([@bib41]). TIDAL outputs were sorted for *P*-element insertions and the insertion coordinates were compared across the *HISR* lines using SQL queries in MS-Access. To calculate the Single Nucleotide Polymorphism (SNP) profiles, paired-end reads were mapped to the Dm6 *ISO1* genome with 'BWA MEM'([@bib34]) using default parameters. PCR duplicates are removed with Picard and SNPs are called with GATK HaplotypeCaller ([@bib13]; [@bib14]; [@bib37]). We then generated the nucleotide distribution for each SNP to ensure that there are at least 20 reads supporting each SNP. Then, we created a unified SNP list by using the union of SNPs from all libraries and carefully noted if each SNP is present in each library. The SNP counts were binned by 5 kb segments and converted into a graphical representation as differences between the reference genome and strain/line in [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}.

Ovary small RNA sequencing and analysis {#s4-7}
---------------------------------------

To remove the 2S rRNA from *Drosophila* ovaries, we adapted a protocol from our previous Q-sepharose beads matrix technique ([@bib32]). About 50 ovaries per parental *Har* and *ISO1* strains and *HISR* lines were dissected from young adult females. Ovaries were then lysed in ice cold 500 ul Elution Buffer (20 mM Hepes pH 7.9 (with KOH), 10% glycerol, 400 mM KOAc, 0.2 mM EDTA, 1.5 mM MgCl2, 1.0 mM DTT, 1X Roche Complete EDTA-free Protease Inhibitor Cocktail) using one freeze-thaw cycle and pulverizing with a blue plastic pestle. A 1.5 ml aliquot of Q-Sepharose FF matrix suspension was washed 1X in water, then 3X in Elution buffer, then incubated for 10 min with the ovaries lysate with occasional agitation in cold room. Ribosomal RNA gets bound by the Q-sepharose, while small RNA RNPs remains in the elution buffer. Elution buffer was removed and then subjected to small RNA extraction with the Tri-reagent protocol. The precipitated small RNAs where then converted into Illumina libraries using the NEBNext Small RNA Library Construction kit. One modification we employed during the overnight linker ligation is to supplement the reactions to 12.5% PEG 8000 to reduce the potential sequence biases from T4 RNA ligase activity.

Small RNA libraries were sequenced as 75 bp single end reads on the NextSeq550. Adapters for the small RNA libraries were removed with CutAdapt and then mapped to the *Drosophila* transposon consensus sequences from RepBase and Flybase using Bowtie v1 with up to two mismatches and R plotting scripts as applied in our previous published studies on *Drosophila* piRNAs ([@bib12]; [@bib55]).

RT-qPCR analysis of *P*-element expression in gonadal dysgenesis and pupal lethality {#s4-8}
------------------------------------------------------------------------------------

For this assay, 5--10 pairs of ovaries were dissected from 3 to 5 day old F1 females of dysgenic and non-dysgenic cross with *Har* and *ISO1*, as well as with *Har* and *HISR-D46.* RNA was extracted from such ovaries and integrity checked by running 1 µg RNA at 2% Agarose II gel (Fischer BioReagents). 3 µg was reverse transcribed using Protoscript RT enzyme (NEB) as per manufacturer's protocol and negative RT control was carried out similarly without RT enzyme. 50 ng of cDNA was used for setting up rp49 PCR reactions (as described above) from RT and corresponding negative RT reactions to evaluate DNA contamination. qPCR reactions for *P*-element ORF2, ORF3, IVS3 were also carried out as genomic qPCR reactions with 20 ng cDNA input and ΔCt were calculated similarly using rp49 RNA levels.

In the RT-qPCR analysis of *H{P delta\[2-3\]}* gene expression in gonadal dysgenesis and pupal lethality, 5--10 pairs of ovaries and corresponding carcass were dissected from F1 females of pupal lethality crosses conducted at 18 °C. RNA extraction, reverse transcription, PCR and qPCR reactions were carried out similarly as above. ΔCt were calculated similarly using rp49 RNA levels. Fold change values were obtained from normalizing F1 carcass *P*-element RNA levels to *H{P delta\[2-3\]}* carcass and F1 ovary *P-element* RNA levels were normalized to *H{P delta\[2-3\]}* carcass in [Figure 7---figure supplement 2](#fig7s2){ref-type="fig"}.

Isolation of *HISR-N17* autosomes for modulating *Har-P* genomic dosage {#s4-9}
-----------------------------------------------------------------------

*HISR-N17* autosomes were isolated first by crossing virgin *HISR-N17* females with Sp/CyO;TM6b/Sb stock males and using virgin F1 females with CyO and TM6 to cross again with Sp/CyO;TM6b/Sb. F2 males with either *HISR-N17* Chr2 or *HISR-N*17 Chr3 were crossed to virgin *H{P delta\[2-3\]}.* All crosses were performed in triplicates at 25 °C. F3 pupal lethality was recorded on 16^th^ day of the *H{P delta\[2-3\]}* crosses.
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**Acceptance summary:**

This paper provides mechanistic insights a long-studied form of hybrid dysgenesis in *Drosophila* in which paternally transmitted *P*-element transposons induce ovarian atrophy when their transposition is not silenced by maternal piRNAs, as occurs when the mothers do not contain *P*-elements. It was previously observed that there is variation in the extent to which different paternal *P*-element containing strains induce this gonadal dysgenesis (GD). This paper presents a variety of data that suggest that the GD-triggering transposition events typically involve truncated forms of the *P*-element mobilized by transposase expressed from intact *P*-elements. This kind of relationship between truncated and intact transposons is common, occurring in plants (MITEs) and mammals (SINEs/LINEs), but is typically viewed as a parasites of parasites relationship. This work reconciles previous work on the differential strength of GD induction, and, more generally, demonstrates that this form of mobilization of non-protein coding transposons can have important functional consequences. The authors also offer some indirect evidence for paternal imprinting on *P*-elements that potentially explains the lack of lethality and male fertility in these crosses, although more work is needed to validate this hypothesis and understand its mechanism. The paper should be interesting to researchers interested in transposons and transposon silencing as well as those studying hybrid inviability and speciation.

**Decision letter after peer review:**

Thank you for submitting your article \"*Har-P*, a short *P*-element variant, weaponizes *P-*transposase to severely impair *Drosophila* development\" for consideration by *eLife*. Your article has been reviewed by two peer reviewers, and the evaluation has been overseen by Michael Eisen acting as Reviewing Editor. The reviewers have opted to remain anonymous.

The paper stimulated a lively discussion between the reviewers and editors, who all found the work to be intriguing and the experiments well-executed. But, as discussed below, the reviewers had several concerns about the significance and novelty of the findings that will need to be addressed if the paper is to be published in *eLife*.

The manuscript by Sricastav et al. focuses on the serendipitous identification in lines derived from a wild *P*-element-containing *Drosophila* strain (Harwich) of a small *P*-element derivative, *Har-P*, which is efficiently mobilized in the absence of inhibitory piRNAs, and, the authors assert, plays an important role in gonadal dysgenesis.

One immediate issue with the manuscript was that it was a bit hard to follow the series of experiments and their logic, and this will have to be improved for the manuscript to reach the wide and diverse audience of *eLife*. As we see it the series of experiments and observations are:

1\) In an effort to map the basis for the gonadal dysgenesis induced by the Harwich (Har) line of *D. melanogaster*, the authors generated a series of hybrid lines between *Har* and a non-GD inducing line such that the lines were expected to only contain a small fraction of the *Har* genome. The idea was to characterize the GD potential of these lines to zero in on genomic regions responsible for GD.

2\) In analyzing these lines \"*HISR*\" lines, the authors realized that a significant amount of *P*-element mobilization had occurred during their generation, making the initial goal of the experiment no longer possible.

3\) However they also realized that a large fraction of the mobilized *P*-elements were actually a short version of a *P*-element, which they name *Har-P*. Both GD inducing (*HISR-D*) and non-GD inducing (*HISR-N*) lines had large numbers of de novo *Har-Ps*. The difference between them appeared to be that the *HISR-D* lines retained intact *P*-elements while the *HISR-N* lines lost them.

4\) For reasons that are not clearly outlined in the manuscript, the authors pursued the hypothesis that the *Har-Ps* were responsible for the strong GD induction from the *Har* and *HISR-D* lines, with the difference between the *HISR-D* and *HISR-N* lines being the presence of a full-length transposase to mobilize them.

5\) The authors analyzed GD in offspring of crosses of various *Har-P*+ and *Har-P*- males with *P*-element naive females either expressing or not expressing P-transposase in the germline. The presence of *P*-transposase in the germline restored GD in *Har-P*+ lines that do not induce it on their own, consistent with the hypothesis that the mobilization of *Har-P* by *P*-transposase encoded by intact *P*-elements is responsible for GD.

All reviewers note the high technical quality of the experiments and found the individual results to be convincing. We have, however, two broad concerns.

Major concern 1: Are *Har-Ps* responsible for the GD phenotype?

While the model -- that, in the presence of *P*-transposase, the small size of *Har-Ps* leads to their preferential mobilization and ultimately to GD -- is plausible and consistent with data, the experiments do not definitively establish this. Indeed all of the lines that show GD in the presence of germline *P*-transposase in Figure 6B have other difference to the ones that do not than simply the presence of *Har-Ps*. An alternative model, for example, would be that the proliferation of *Har-Ps* is a consequence of a property of these lines that also leads to GD. We would like to see a better argument, ideally with some data, that points more definitively to the presence of *Har-Ps* as the proximal cause of GD.

Furthermore, we would like to see some additional discussion, again ideally backed by data if it is available, of the properties of *Har-Ps* that make function in this way. Several specific questions came up in this regard. How does *Har-P* compare to the KP or the small *P*-elements on *BIRM2* or *BIRM3*? Does *Har-P* make a protein? Why is *Har-P* better at transposition? The authors speculate that it has to do with pairing of the *P-*element ends, but what features of *Har-P* might be causing this. It has generally been observed that larger *P*-elements (and transposons in general) are mobilized less efficiently. So is it just that *Har-Ps* are small, or is there something in particular about the way they are small that allows them to be predicted mobilize more efficiently?

Major concern 2: The results don\'t differ from expectation given what was already known about *P*-elements and GD.

The most likely proximate cause of GD in the presence of *P*-transposase and *P*-element DNA is double stranded breaks occurring at the ends of the *P*-element (at the TIRs). As *Har-Ps* contain the TIRs, it\'s expected that they would increase GD severity: the more TIRs that there are, the more double stranded breaks, as long as there is some active transpose around to recognize them and perform the DSB. The fact that the transpose assembles more efficiently on short elements (as pointed out in the manuscript) probably amplifies the effect of these TIRs.

In fact, the copies of TIRs are expected to be more important that the copies of full-length *P*, as it is known already that very little protein is needed to cause dysgenesis. In fact, as the N and D versions of the lines differ primarily in the presence of full-length *P-*element content than in *Har-P* (Figure 5C), the results more clearly confirm the importance of full-length *P*-element in GD.

In short, the results of this experiment seem more or less consistent with what would have been expected given what is known about *P-*elements and GD. That is, the results seem confirmatory rather than surprising, as is portrayed in the paper. We are, however, open to being convinced that we have missed something here.

10.7554/eLife.49948.sa2

Author response

> \[...\] Major concern 1: Are Har-Ps responsible for the GD phenotype?
>
> While the model -- that, in the presence of P-transposase, the small size of Har-Ps leads to their preferential mobilization and ultimately to GD -- is plausible and consistent with data, the experiments do not definitively establish this. Indeed all of the lines that show GD in the presence of germline P-transposase in Figure 6B have other difference to the ones that do not than simply the presence of Har-Ps. An alternative model, for example, would be that the proliferation of Har-Ps is a consequence of a property of these lines that also leads to GD. We would like to see a better argument, ideally with some data, that points more definitively to the presence of Har-Ps as the proximal cause of GD.

We thank the reviewers for raising this concern. We are confident that the very short *P-*element variant is the most likely ammunition that P-transposase acts upon to drive the severest forms of GD. Although the *HISR-D* and HISR-N strains are related to the parental *Har* only in terms of de novo mobilized *P-*elements, the genomic location patterns of these de novo *P-*elements are all distinct from each other (Figure 4D). In addition, the large majority of the genomic background of *HISR* strains is *ISO1*, thereby mitigating the concern of an additional property besides the *Har-Ps* that might be lurking amongst the different strains' genomic background.

Nevertheless, we have now added some new data and text pointing out that our examination of multiple strains that are completely independent in origin from *Har*. In Figure 1 and Figure 5---figure supplement 2, we point to *pi\[2\]*, *RAL-42*, and *RAL-377* that each have short *P*-variants like *Har-P*, and these strains all cause very severe GD like Har. In contrast, *OreR-TK*, *OreR-MOD*, *RAL-508*, and *RAL-855* all with the longer *KP*-variants and *Lerik-P* with two full-length *P-*elements; these all do not cause severe GD. The new text describing Figure 5---figure supplement 2 is in the last paragraph of the subsection "Dispersed *P-*element landscapes indicate de novo transposition in *HISR* lines".

In total, our conclusion is well supported by our data, given the multiple tests we have performed with multiple strains of completely independent origins all fitting with the pattern that very short *Har-P* like variants are present in strains that cause strong GD.

> Furthermore, we would like to see some additional discussion, again ideally backed by data if it is available, of the properties of Har-Ps that make function in this way. Several specific questions came up in this regard. How does Har-P compare to the KP or the small P-elements on BIRM2 or BIRM3? Does Har-P make a protein?

We thank the reviewers for this question, and we wish to point out that Figure 5B indeed had diagrammed the cloning and sequencing analysis of the short *P-*element variant from the *Birm* strain, which contains both the *Birm2* (chr2) and *Birm3* (chr3) backgrounds and is the only available *Birm* strain from the BDSC fly stock center. These *Birm P-*element variants are only slightly longer than *Har-P* and the *pi\[2\]-P* variants at 679bp vs. 629bp and 609bp, respectively. But since *Birm* is a completely independent strain from *Har* and the *HISR-N* strains, yet has the same capacity as *HISR-N* strain to contribute to increased GD in crosses with *P*-transposase (Figure 6B), this is another example strongly supporting the model for the short P variants serving as the genomic ammunition to weaponize *P*-transposase to cause GD.

However, to our surprise, we found all the *Har-P* variants we cloned have the minimum overall length on 5' and 3' end required for transposition (Mullins et al., 1987) that include all the sites functional transposase interacts. Hence, we propose *Har-Ps* in Harwich, *HISRs*, *pi\[2\]*, *Birm*, and *RAL-42*, and *RAL-377* drive GD by higher transposition rates, not by its protein product. This data is now described in the subsection "Dispersed *P-*element landscapes indicate de novo transposition in *HISR* lines" and in new Figure 5---figure supplement 2.

It is very unlikely for *Har-P* to encode a protein because the massive deletion removes segments from all 4 ORFs and within 110bp of the start codon is a stop codon, with then many additional subsequent stop codons. We have added the following text: "In addition, these short *P-*element variants seemed unlikely to translate into a protein due to multiple premature stop codons introduced by the massive internal deletion."

> Why is Har-P better at transposition? The authors speculate that it has to do with pairing of the P-element ends, but what features of Har-P might be causing this. It has generally been observed that larger P-elements (and transposons in general) are mobilized less efficiently. So is it just that Har-Ps are small, or is there something in particular about the way they are small that allows them to be predicted mobilize more efficiently?

We thank the reviewers for this question, and wish to highlight sentences in the Introduction and Discussion citing elegant biochemical studies by Donald Rio's lab in 2007, which used atomic force microscopy to measure recombinant *P*-transposase assembly of a synapsis complex on full-length *P-*element DNA *and* the highly short *P-*element variant from the *pi\[2\]* strain that is almost the same as the *Har-P* element. The key finding in Tang et al., 2007 is that *P*-transposase transposition complex assembles \~180-fold More Efficiently on the very short *P-*element variant compared to full-length *P-*element. Our genetics and genomics data now provide clear support for how the more efficient assembly of *P*-transposase synapsis complexes on the short variant can actually lead to more efficient transposition in vivo and this hyper transposition activity of the short variant is the driver of severe GD.

Finally, we have added more text to the second paragraph of the Discussion and Figure 7---figure supplement 2C, where we have added additional control crosses with other *P-*element-based transgenes that were mobilized by *P*-transposase into transgenic strains before but are not strong triggers of GD like the *Har-P* elements when re-crossed to *P*-transposase.

> Major concern 2: The results don\'t differ from expectation given what was already known about P-elements and GD.
>
> The most likely proximate cause of GD in the presence of P-transposase and P-element DNA is double stranded breaks occurring at the ends of the P-element (at the TIRs). As Har-Ps contain the TIRs, it\'s expected that they would increase GD severity: the more TIRs that there are, the more double stranded breaks, as long as there is some active transpose around to recognize them and perform the DSB. The fact that the transpose assembles more efficiently on short elements (as pointed out in the manuscript) probably amplifies the effect of these TIRs.
>
> In fact, the copies of TIRs are expected to be more important that the copies of full-length P, as it is known already that very little protein is needed to cause dysgenesis. In fact, as the N and D versions of the lines differ primarily in the presence of full-length P-element content than in Har-P (Figure 5C), the results more clearly confirm the importance of full-length P-element in GD.

We thank the reviewers for raising this issue, however the true novelty of our study is to point out that strains containing various longer *P-*element variants (KP and full-length) bearing intact TIRs are poor inducers of GD. Our multiple tests in multiple independent strains shows that only strains bearing very short *Har-P* like variants coupled with a full-length element that can express transposase can induce severe GD, but strains like *Lerik-P* that contains only a full-length *P-*element with TIRs does not induce severe GD.

Since *P-*element structural variants often exhibit internal deletion only, most variants retain TIRs. Hence, several previous studies that found lack of correlation between *P-*element copy and GD, already refuted the 'more TIR -- more GD model'. Due to genetic partitioning of *P-*element variants in *HISRs* and other combination of *P-*element variants in wt strains, we show for the first time the cause of GD variation.

In addition, the *delta\[2-3\]* strain only expresses *P*-transposase but Lacks TIRs in the *P*-transposase transgene, therefore when this is crossed with *HISR-Ns*, *Birm* and certain *RAL-42* and *RAL-377* strains with very short *P-*elements, severe GD is induced, whereas longer *P-*elements in *OreR* and other *RAL-508* and *RAL-855* strains are incapable of severe GD even when crossed with *delta\[2-3\]*.

We respectfully assert this is a highly novel finding not only in the *P-*element literature but also in the transposon literature for a DNA element in a metazoan.

> In short, the results of this experiment seem more or less consistent with what would have been expected given what is known about P-elements and GD. That is, the results seem confirmatory rather than surprising, as is portrayed in the paper. We are, however, open to being convinced that we have missed something here.

We thank the reviewers for being open to being convinced that they may have missed something here.

Our study is the first to pinpoint that actual sets of *P-*elements that are causative for severe (\~100%) GD as observed with Har.

Our study is the first to show that it is the short *P-*elements that when be recombined with *P*-transposase is causative for severe GD, because our data clearly show that other strains with longer but still internally-truncated *P-*elements do Not induce strong GD when recombined with *P*-transposase.

Our study is the first to show genetically that the shortest *P-*element variant mobilizes much more efficiently than the full-length *P-*element.

Our study is the first to show that *P-element* piRNAs in the mother can imprint a silencing mark on *Har-P* loci in sons *that* suppresses somatic *P*-transposase during pupation in the daughters, but then this silencing feature is erased during oogenesis to result in severe GD.

We hope our rebuttal convinces the reviewers to see the merit of this revision that includes new data and can see how our work now advances the field of transposon biology.
